Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunotherapy in sepsis - brake or accelerate?
Folkert Steinhagen, Susanne V. Schmidt, Jens‐Christian Schewe, et al.
Pharmacology & Therapeutics (2020) Vol. 208, pp. 107476-107476
Open Access | Times Cited: 108

Showing 1-25 of 108 citing articles:

Probiotics in Medicine: A Long Debate
Elisavet Stavropoulou, Eugenia Bezirtzoglou
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 213
Inflammation and Cell Death of the Innate and Adaptive Immune System during Sepsis
Christina Nedeva
Biomolecules (2021) Vol. 11, Iss. 7, pp. 1011-1011
Open Access | Times Cited: 144
The gasdermin family: emerging therapeutic targets in diseases
Cheng‐long Zhu, Sheng Xu, Ruoyu Jiang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 24
Targeting Cytokines, Pathogen-Associated Molecular Patterns, and Damage-Associated Molecular Patterns in Sepsis via Blood Purification
Kazuhiro Moriyama, Osamu Nishida
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8882-8882
Open Access | Times Cited: 98
The pathophysiology of SARS-CoV-2: A suggested model and therapeutic approach
Gerwyn Morris, Chiara C. Bortolasci, Basant K. Puri, et al.
Life Sciences (2020) Vol. 258, pp. 118166-118166
Open Access | Times Cited: 95
Modulation of the Innate Immune Response by Targeting Toll-like Receptors: A Perspective on Their Agonists and Antagonists
Stefano Federico, Luca Pozzetti, Alessandro Papa, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 22, pp. 13466-13513
Closed Access | Times Cited: 93
Parallels in Sepsis and COVID-19 Conditions: Implications for Managing Severe COVID-19
Charles Ochieng’ Olwal, Nora Nghochuzie Nganyewo, Kesego Tapela, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 87
Endothelial dysfunction in neuroprogressive disorders—causes and suggested treatments
Gerwyn Morris, Basant K. Puri, Lisa Olive, et al.
BMC Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 70
Biomimetic Immunosuppressive Exosomes that Inhibit Cytokine Storms Contribute to the Alleviation of Sepsis
Yinan Li, Heng Zhang, Caihong Chen, et al.
Advanced Materials (2022) Vol. 34, Iss. 19
Open Access | Times Cited: 64
Multi-compound and drug-combination pharmacokinetic research on Chinese herbal medicines
Chuan Li, Weiwei Jia, Junling Yang, et al.
Acta Pharmacologica Sinica (2022) Vol. 43, Iss. 12, pp. 3080-3095
Open Access | Times Cited: 64
Adjuvant therapeutic plasma exchange in septic shock
Sascha David, Christian Bode, Christian Putensen, et al.
Intensive Care Medicine (2021) Vol. 47, Iss. 3, pp. 352-354
Open Access | Times Cited: 62
Macrophage-Membrane-Camouflaged Nonviral Gene Vectors for the Treatment of Multidrug-Resistant Bacterial Sepsis
Hongmei Cao, Yang Gao, Haixue Jia, et al.
Nano Letters (2022) Vol. 22, Iss. 19, pp. 7882-7891
Closed Access | Times Cited: 42
SIRS, SOFA, qSOFA, and NEWS in the diagnosis of sepsis and prediction of adverse outcomes: a systematic review and meta-analysis
Xia Qiu, Yupeng Lei, Ruixi Zhou
Expert Review of Anti-infective Therapy (2023) Vol. 21, Iss. 8, pp. 891-900
Closed Access | Times Cited: 35
Targeting the host response in sepsis: current approaches and future evidence
Christian Bode, Sebastian Weis, Andrea Sauer, et al.
Critical Care (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 31
Towards personalized medicine: a scoping review of immunotherapy in sepsis
Marleen A. Slim, Niels van Mourik, Lieke Bakkerus, et al.
Critical Care (2024) Vol. 28, Iss. 1
Open Access | Times Cited: 12
Toll‐like receptors (TLRs) in cancer; with an extensive focus on TLR agonists and antagonists
Ali Keshavarz, Atieh Pourbagheri‐Sigaroodi, Parisa Zafari, et al.
IUBMB Life (2020) Vol. 73, Iss. 1, pp. 10-25
Open Access | Times Cited: 60
NLRP3 inflammasome inhibition attenuates sepsis-induced platelet activation and prevents multi-organ injury in cecal-ligation puncture
Denise C. Cornelius, Olivia K. Travis, Robert Tramel, et al.
PLoS ONE (2020) Vol. 15, Iss. 6, pp. e0234039-e0234039
Open Access | Times Cited: 56
Disulfiram-loaded lactoferrin nanoparticles for treating inflammatory diseases
Ante Ou, Jiaxin Zhang, Yuefei Fang, et al.
Acta Pharmacologica Sinica (2021) Vol. 42, Iss. 11, pp. 1913-1920
Open Access | Times Cited: 55
Clinical and biochemical endpoints and predictors of response to plasma exchange in septic shock: results from a randomized controlled trial
Klaus Stahl, Philipp Wand, Benjamin Seeliger, et al.
Critical Care (2022) Vol. 26, Iss. 1
Open Access | Times Cited: 37
Endotoxin in Sepsis: Methods for LPS Detection and the Use of Omics Techniques
Grazia Maria Virzì, Maria Mattiotti, Massimo de Cal, et al.
Diagnostics (2022) Vol. 13, Iss. 1, pp. 79-79
Open Access | Times Cited: 37
Management of Sepsis and Septic Shock: What Have We Learned in the Last Two Decades?
Shiwani Kamath, Hiba Hammad Altaq, Tony Abdo
Microorganisms (2023) Vol. 11, Iss. 9, pp. 2231-2231
Open Access | Times Cited: 21
Enhancing Spns2/S1P in macrophages alleviates hyperinflammation and prevents immunosuppression in sepsis
Chao Fang, Pan Ren, Ganlan Bian, et al.
EMBO Reports (2023) Vol. 24, Iss. 8
Closed Access | Times Cited: 17
Exosome: The Regulator of the Immune System in Sepsis
Peng Qiu, Jing Zhou, Jin Zhang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 38
Characterization of immune-related genes and immune infiltration features for early diagnosis, prognosis and recognition of immunosuppression in sepsis
Jianhai Lu, Rui Chen, Yangpeng Ou, et al.
International Immunopharmacology (2022) Vol. 107, pp. 108650-108650
Open Access | Times Cited: 27
Prevalence of New-Onset Atrial Fibrillation and Associated Outcomes in Patients with Sepsis: A Systematic Review and Meta-Analysis
Bernadette Corica, Giulio Francesco Romiti, Stefania Basili, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 4, pp. 547-547
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top